Patient with melanoma receives tumor-infiltrating lymphocyte therapy
Vanderbilt-Ingram Cancer Center has treated its first patient in a newly launched therapy program that magnifies the power of a person’s natural defense system against tumors.
Vanderbilt-Ingram Cancer Center has treated its first patient in a newly launched therapy program that magnifies the power of a person’s natural defense system against tumors.
Hematologists with Vanderbilt-Ingram Cancer Center have published strategies for implementing outpatient treatment programs for bispecific antibodies, an immunotherapy that can cause adverse reactions.
Ben Ho Park, MD, PhD, Professor of Medicine (Hematology and Oncology) and Director of the Vanderbilt-Ingram Cancer Center, was recently announced as the recipient of the American Association for Cancer Research's 2025 Distinguished Lectureship in Breast Cancer Research award.
Jennifer Lewis, MD, Assistant Professor of Medicine, and colleague Lucy Spalluto, MD (Radiology and Radiological Sciences), were recently awarded a $1 million grant from AstraZeneca to understand and improve veteran access to mobile lung cancer screening.
VUMC recently held a Directorship Celebration to honor 23 leaders, including seven in the Department of Medicine, from across the enterprise in clinical care, research, education and administration.
VUMC researchers have secured a funding extension from the Advanced Research Projects Agency for Health (ARPA-H) to expand use of an artificial intelligence-guided platform for extracting and organizing critical information from unstructured clinical notes and reports in medical records.
Among those advocating on Capitol Hill were three Department of Medicine faculty, Drs. Alvin Powers (Diabetes, Endocrinology and Metabolism), Patrick Hu (Hematology and Oncology) and Hyun Song (Cardiovascular Medicine).
Among the new VICC leaders are Department of Medicine Hematology and Oncology faculty members Drs. Douglas Johnson and Kristen Ciombor.